Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The U.S. Department of Justice has requested documents from the country’s two largest dialysis chains on their relationship to the American Kidney Fund and whether the fund favored their patients over others in premium assistance programs.
Two Pore Guys (2PG) have announced a collaboration with oncologists at the University of California, San Francisco (UCSF) to evaluate its handheld nanopore-based platform capable of detecting cell-free circulating tumor DNA from liquid biopsies.
Some have difficulty accessing mental healthcare, but a new smartphone application is hoping to remove road blocks. According to a new study published in Journal of Medical Internet Research, users of the IntelliCare app experienced lower rates of depression and anxiety.
New research from Michigan State University has led to the development of a new skin cancer drug with a chemical compound may stop the spread of melanoma by as much as 90 percent.
A new app developed at Queen Mary University of London (QMUL) and Kingston University in the United Kingdom uses games and rewards to incentivize players to kick their smoking habit.
In a multiple study analysis, researchers found engaging patients in a video game interface displayed through an app could be an effective treatment of depression by targeting underlying cognitive issues.
Managed Health Care Associates, a healthcare services and software company in Chicago, has released its new Home Infusion Pharmacy, which will help home infusion pharmacy customers compete in a value-based reimbursement market.
Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.